Information Library
Results for: Consulting
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Quintiles Backs Change to Marketing Mix as NHS Reforms Take Hold
Press Release — READING, UK – 30 May, 2012 – Quintiles has released the first in a series of briefing papers looking at how market access strategies can
-
UK Market Access Insight Brief
White Paper — May 30, 2012
Insight Briefing series on Market Access in key European countries -
UK Market Access Insight Brief
Hear from the Experts — May 30, 2012
Quintiles' Robert Taylor and Gareth Williams discuss the impact of healthcare reform on commercialisation strategy for the UK. -
UK Market Access Insight Brief
Podcast — May 30, 2012
Insight Briefing series on Market Access in key European countries -
Nordic Region Market Access
Presentation — May 22, 2012
The countries of the Nordic region are, together, one of the most important pharmaceutical marketplaces in Europe. Their significance is due to their combined size, -
Demonstrating Value Driving Commercial Success
Brochure — May 17, 2012
Global Market Access and Commercialization, a core practice from Consulting at Quintiles, stands ready to help you navigate the value substantiation process, from developing and demonstrating your product’s value platform to assisting in winning a preferred position on payer formularies and negotiating favorable pricing and reimbursement. -
Devising OTC strategies for devices
Hear from the Experts — May 14, 2012
Registering an OTC product as a medical device can provide a faster and more cost-effective way of entering the European market, according to Quintiles’ Dr Peter Lassoff. -
Optimizing Clinical Development Sourcing
Case Study — May 1, 2012
The US Affiliate of a top 10 European based pharma company came to the realization that their clinical development sourcing model had evolved within its late stage clinical operations function. -
Podcast: Addressing Compliance Challenges
Hear from the Experts — April 20, 2012
Bob Rhoades and Marie McDonald, from Consulting at Quintiles, discuss some of the top reasons biopharmaceutical companies fail to make progress on the compliance maturity curve. -
Robust Audit Programs
Hear from the Experts — April 20, 2012
Good internal audit programs and auditing practices enable an organization to evaluate the effectiveness of its Quality Management System, and promote continuous improvement.
